Surgery Doctors in Natchitoches, LA Accepting Medicare
4 Surgery doctors found. Showing 1 - 4
 Dr. Steven Michael Jackson, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Keyser Ave, Natchitoches, LA 71457 Phone: 318-354-2555 Fax: 318-354-0101 |
Dr. Damian Angelo Defrancesch, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 501 Keyser Ave, Natchitoches, LA 71457 Phone: 318-354-2555 Fax: 318-354-0101 |
Dr. Willliam A Ball Jr., M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Keyser Ave, Natchitoches, LA 71457 Phone: 318-214-5770 |
William Daniel Zeichner, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 651 Bienville Cir, Natchitoches, LA 71457 Phone: 318-357-1200 Fax: 318-352-3644 |
News Archive
Researchers discover immune regulator that appears to dictate glioblastoma
Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.
How many hospital infections? New facts discredit CDC's official number
On Wednesday, April 16th the House Committee on Government Oversight and Reform will hold a hearing on whether the federal government is doing enough to prevent hospital infections.
Majority of seniors switch their primary care physicians because they are forced to
Nearly nine out of ten seniors switch their primary care physicians because they are forced to – not by choice. That's the finding of research published in the November edition of The Journal of the American Board of Family Practice.
Apixaban superior to enoxaparin in reducing venous thromboembolism in total knee replacement surgery patients
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc., was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet. The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin.
› Verified 3 days ago
Internal Medicine
Family Medicine
Orthopaedic Surgery
Psychiatry & Neurology
Surgery
Pediatrics
Obstetrics & Gynecology
Radiology
Critical Care Medicine
Physical Medicine & Rehabilitation
Cardiovascular Disease